Biobots and anthropobots: towards a new medicine?
If cells can survive and reassemble after death, can they be used for medical treatments? This is a fascinating avenue that researchers are exploring.
They imagine biobots, multicellular structures capable of performing specific tasks in the human body. Better yet, anthropobots could be created from a patient’s own cells to perform specific medical missions without causing immune rejection.
For example:
Unclogging arteries: anthropobots could dissolve cholesterol plaques and prevent heart attacks.
Treating cystic fibrosis: by eliminating excess mucus in the lungs.
Transporting drugs: by precisely targeting diseased areas while limiting side effects.
How far can this discovery go?
Although promising, this approach raises many questions. What are the limits of this cellular plasticity? Can we really control these new structures to avoid adverse effects?
Researchers estimate that these reassembled cells would not survive more than 60 days, thus limiting the risks of uncontrolled proliferation. But further studies are needed to better understand these mechanisms.
This “third state” could well redefine our understanding of life and death. And above all, it opens up incredible medical perspectives, ranging from cell regeneration to tailor-made treatments. One thing is certain: we are only at the beginning of a scientific revolution.
Thank you for visiting the site
